|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Inverness Medical Innovations, Inc. (AMEX: IMA), a provider of diagnostic products for women’s health and chronic disease self-management. |
|---|---|
| Transferring Party | Thermo BioStar, the point-of care and rapid diagnostics business of Thermo Electron, a maker of laboratory tools. |
| Sector | Diagnostics |
| Date | September 19, 2005 |
| Analysis Provides Inerness with complementary product lines, and a direct sales force of 55 people to market directly to doctors' offices and hospitals. Deal value $52.5 million. Thermo BioStar is profitable and had revenue for the first half of 2005 of $18.5 million. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |